Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
UCSD's $516,000 temporary executive
Interim health system shoe-filler collects retroactive six-figure cash
Patricia Maysent
The intrigue surrounding the saga of UCSD Health's departed top man Paul Viviano continues, with a lengthening search underway to fill the vacancy, and approval by U.C. regents of a $516,000 interim appointment.
Paul Viviano
Paul Aisen
As previously reported here in July, Viviano abruptly abandoned his $831,147 job as chief executive officer for the University of California, San Diego Health System and associate vice chancellor for UC San Diego Health Sciences.
The administrator told the Union-Tribune that he found it "agonizing" to leave town to take over as president and chief executive of the Children’s Hospital of Los Angeles, but wanted to be nearer to his family in Huntington Beach.
The surprise shift came amid the tumult of the university’s costly legal wrangle with Alzheimer’s disease expert Paul Aisen, who resigned in June, alleging that mismanagement of the school's research programs had played havoc with his work.
A court brief filed by the University of Southern California, which lured Aisen to its faculty in a high-dollar research deal, contended that UCSD had “pressured Dr. Aisen to move [the Alzheimer’s program] to the UCSD campus so that UCSD could collect indirect costs of up to 55 percent, a move which would have crippled the program financially by diverting too much grant funding from research projects into UCSD’s Administration.”
In addition, a 2014 audit called out a series of issues regarding UCSD's handling of human body donations to the school.
Since Viviano's summer resignation, the chief executive part of his job has been filled by Patricia Maysent, who worked under him as executive director of Strategic and Business Development.
"Ms. Maysent has been serving as the CEO of UC San Diego Health System since Mr. Viviano’s departure, without any additional compensation beyond her current salary of $299,252," says a November 20 regents report.
"Since her temporary role as interim CEO is expected to continue for up to eight more months, the temporary salary is proposed to properly compensate her for her services retroactive to the date she assumed the role. Because it is retroactive, this is considered an exception to policy.”
Adds the document, "The campus proposes a base salary of $430,000 while she is in this interim role, reflecting a temporary increase of 43.7 percent.”
In addition to the base pay, the report says, Maysent will also get bonus cash from the university's Clinical Enterprise Management Recognition Plan, "with a target award of 20 percent of base salary ($86,000) and a maximum potential award of 30 percent of base salary ($129,000) for the period served as Interim Chief Executive Officer.”
Her total "target cash compensation" is listed as $516,000.
"At the conclusion of the interim appointment, Ms. Maysent will return to her former role as Executive Director, Strategic and Business Development, and her total cash compensation will revert to her total cash compensation in effect as of August 8, 2015, plus any adjustments resulting from salary programs implemented during the interim appointment."
Here's something you might be interested in.
UCSD's $516,000 temporary executive
Interim health system shoe-filler collects retroactive six-figure cash
UCSD's $516,000 temporary executive
Interim health system shoe-filler collects retroactive six-figure cash
Patricia Maysent
The intrigue surrounding the saga of UCSD Health's departed top man Paul Viviano continues, with a lengthening search underway to fill the vacancy, and approval by U.C. regents of a $516,000 interim appointment.
Paul Viviano
Paul Aisen
As previously reported here in July, Viviano abruptly abandoned his $831,147 job as chief executive officer for the University of California, San Diego Health System and associate vice chancellor for UC San Diego Health Sciences.
The administrator told the Union-Tribune that he found it "agonizing" to leave town to take over as president and chief executive of the Children’s Hospital of Los Angeles, but wanted to be nearer to his family in Huntington Beach.
The surprise shift came amid the tumult of the university’s costly legal wrangle with Alzheimer’s disease expert Paul Aisen, who resigned in June, alleging that mismanagement of the school's research programs had played havoc with his work.
A court brief filed by the University of Southern California, which lured Aisen to its faculty in a high-dollar research deal, contended that UCSD had “pressured Dr. Aisen to move [the Alzheimer’s program] to the UCSD campus so that UCSD could collect indirect costs of up to 55 percent, a move which would have crippled the program financially by diverting too much grant funding from research projects into UCSD’s Administration.”
In addition, a 2014 audit called out a series of issues regarding UCSD's handling of human body donations to the school.
Since Viviano's summer resignation, the chief executive part of his job has been filled by Patricia Maysent, who worked under him as executive director of Strategic and Business Development.
"Ms. Maysent has been serving as the CEO of UC San Diego Health System since Mr. Viviano’s departure, without any additional compensation beyond her current salary of $299,252," says a November 20 regents report.
"Since her temporary role as interim CEO is expected to continue for up to eight more months, the temporary salary is proposed to properly compensate her for her services retroactive to the date she assumed the role. Because it is retroactive, this is considered an exception to policy.”
Adds the document, "The campus proposes a base salary of $430,000 while she is in this interim role, reflecting a temporary increase of 43.7 percent.”
In addition to the base pay, the report says, Maysent will also get bonus cash from the university's Clinical Enterprise Management Recognition Plan, "with a target award of 20 percent of base salary ($86,000) and a maximum potential award of 30 percent of base salary ($129,000) for the period served as Interim Chief Executive Officer.”
Her total "target cash compensation" is listed as $516,000.
"At the conclusion of the interim appointment, Ms. Maysent will return to her former role as Executive Director, Strategic and Business Development, and her total cash compensation will revert to her total cash compensation in effect as of August 8, 2015, plus any adjustments resulting from salary programs implemented during the interim appointment."
Comments